High-purity Eptastigmine API — GMP Certified
Eptastigmine (heptylphysostigmine) is a long-acting acetylcholinesterase inhibitor investigated for the treatment of Alzheimer's disease and dementia. Mediocon Inc manufactures Eptastigmine API to IP/BP/EP/USP standards in its GMP-certified facility in Aurangabad, Maharashtra, India.
Our Eptastigmine API is supplied to CNS pharmaceutical manufacturers and research institutions globally. Full quality documentation and regulatory support is provided for all markets.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Eptastigmine (CAS 101246-68-8) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Eptastigmine is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance